Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer. More info »
Generic Evista is used for treating and preventing osteoporosis (bone thinning) in women who are past menopause. It is also used to reduce the risk of invasive breast cancer in certain women who are past menopause. More info »
Generic Premarin is used for treating certain symptoms of menopause (eg, hot flashes, vaginal dryness or itching). It is used to prevent osteoporosis (weak bones) after menopause in certain patients. It is also used in certain patients to treat low estrogen levels, prostate cancer or breast cancer. More info »
Regarding the effect: I do notice an increase in bloodflow and a better
stamina using the pills (I use 50mg). A side-effect I have noticed is that
my nose clogs up so I seem like I have a cold for an hour or so after taking
one pill. No other side-effects than that.
High prevalence of bone disease in patients referred for pulmonary rehabilitation - Medical Xpress
High prevalence of bone disease in patients referred for pulmonary rehabilitationMedical XpressThere is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And ... - MarketWatch (press release)
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And .
Healthy Advice: Osteoporosis is diagnosed in 2 percent of college aged women - Sulphur Southwest Daily News
Healthy Advice: Osteoporosis is diagnosed in 2 percent of college aged womenSulphur Southwest Daily NewsBy Staff reports Question: I'ma 29-year-old-woman just diagnosed with osteoporosis.
Osteoporosis - Pipeline Review, H1 2012 - New Market Research Report - SBWire (press release)
Osteoporosis - Pipeline Review, H1 2012 - New Market Research ReportSBWire (press release)Boston, MA -- (SBWIRE) -- 05/17/2012 -- Global Markets Direct's, 'Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Osteoporosis therapeutic pipeline.
Aging Population, Growing Awareness and Novel Therapeutics Drives the Global ... - San Francisco Chronicle (press release)
PR WebAging Population, Growing Awareness and Novel Therapeutics Drives the Global .
